Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Sartorius Stedim Biotech S.A. SRTOY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • FR • USD

SharesGrow Score
44/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Sartorius Stedim Biotech S.A. (SRTOY) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is neutral — 1 Hold.

SRTOY Analyst Ratings

Hold
1
Ratings
1 Hold
Based on 1 analysts giving stock ratings to Sartorius Stedim Biotech S.A. in the past 3 months
Rating breakdown
Hold
1 100%
0%
Buy
0 analysts
100%
Hold
1 analysts
0%
Sell
0 analysts

People Also View

BDX
BDX
Becton, Dickinson and Company
$155.73
+0.19%
 ALC
ALC
Alcon Inc.
$79.94
+0.25%
 RMD
RMD
ResMed Inc.
$230.69
+0.19%
 WST
WST
West Pharmaceutical Services, Inc.
$267.93
+3.07%
 HOLX
HOLX
Hologic, Inc.
$76.01
+0.00%
 COO
COO
The Cooper Companies, Inc.
$71.61
-0.13%
 BAX
BAX
Baxter International Inc.
$17.59
-0.23%
 TFX
TFX
Teleflex Incorporated
$125.21
+1.65%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message